Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Active immunisation targeting nerve growth factor attenuates chronic pain behaviour in murine osteoarthritis

von Loga IS. et al, (2019), Annals of the Rheumatic Diseases, 78, 672 - 675

Active vaccination against interleukin-5 as long-term treatment for insect-bite hypersensitivity in horses

Fettelschoss-Gabriel A. et al, (2019), Allergy, 74, 572 - 582

A vaccine against Alzheimer`s disease: anything left but faith?

Bachmann MF. et al, (2019), Expert Opinion on Biological Therapy, 19, 73 - 78

The 5th virus-like particle and nano-particle vaccines (VLPNPV) conference

Engeroff P. and Bachmann MF., (2019), Expert Review of Vaccines, 18, 1 - 3

Induction of Human T-cell and Cytokine Responses Following Vaccination with a Novel Influenza Vaccine

Skibinski DAG. et al, (2018), Scientific Reports, 8

Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases

Klimek L. et al, (2018), Allergo Journal International, 27, 245 - 255

An unexpected protective role of low-affinity allergen-specific IgG through the inhibitory receptor FcγRIIb

Zha L. et al, (2018), Journal of Allergy and Clinical Immunology, 142, 1529 - 1536.e6

The Prospects of an Active Vaccine Against Asthma Targeting IL-5

Bachmann MF. et al, (2018), Frontiers in Microbiology, 9

Treating insect-bite hypersensitivity in horses with active vaccination against IL-5

Fettelschoss-Gabriel A. et al, (2018), Journal of Allergy and Clinical Immunology, 142, 1194 - 1205.e3

A novel recycling mechanism of native IgE-antigen complexes in human B cells facilitates transfer of antigen to dendritic cells for antigen presentation

Engeroff P. et al, (2018), Journal of Allergy and Clinical Immunology, 142, 557 - 568.e6

Biosensor-based selective detection of Zika virus specific antibodies in infected individuals

Cabral-Miranda G. et al, (2018), Biosensors and Bioelectronics, 113, 101 - 107

HealVax

Foerster J. and Bachmann M., (2018), Human Vaccines & Immunotherapeutics, 14, 1546 - 1547

Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System

Mohsen M. et al, (2018), Vaccines, 6, 37 - 37

Vaccination against IL-31 for the treatment of atopic dermatitis in dogs

Bachmann MF. et al, (2018), Journal of Allergy and Clinical Immunology, 142, 279 - 281.e1

Allergens displayed on virus-like particles are highly immunogenic but fail to activate human mast cells

Engeroff P. et al, (2018), Allergy, 73, 341 - 349

Incorporation of tetanus-epitope into virus-like particles achieves vaccine responses even in older recipients in models of psoriasis, Alzheimer’s and cat allergy

Zeltins A. et al, (2017), npj Vaccines, 2

Nanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccines

Leneghan DB. et al, (2017), Scientific Reports, 7

Microcrystalline Tyrosine (MCT®): A Depot Adjuvant in Licensed Allergy Immunotherapy Offers New Opportunities in Malaria

Cabral-Miranda G. et al, (2017), Vaccines, 5, 32 - 32

Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles

Doucet M. et al, (2017), PLOS ONE, 12, e0181844 - e0181844

Therapeutic silence of pleiotrophin by targeted delivery of siRNA and its effect on the inhibition of tumor growth and metastasis

Zha L. et al, (2017), PLOS ONE, 12, e0177964 - e0177964

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?